Metabolomics Profiling of Coronary Heart Disease

NCT05138731 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 821

Last updated 2022-01-14

No results posted yet for this study

Summary

This study sought to assess the diagnostic and prognostic values of metabolomics in coronary artery disease(CAD).

Conditions

  • Biomarkers

Interventions

OTHER

treatments according guidelines

different group intervened with different treatment following guidelines/consensuses accordingly

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    lead OTHER

Principal Investigators

  • Hechun Xia, MA · General Hospital of Ningxia Medical University

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-01-30
Completion
2023-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138731 on ClinicalTrials.gov